Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE Study

Related Experiment Video

Updated: Aug 21, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

Hans Ibsen1, Kristian Wachtell, Michael H Olsen

  • 1Department of Medicine, Glostrup University Hospital, Glostrup, Denmark. haib@glostruphosp.kbhamt.dk

Kidney International. Supplement
|October 16, 2004
PubMed

Insights

Albuminuria, a marker of kidney damage, significantly increases cardiovascular risk in hypertensive patients with left ventricular hypertrophy. This risk escalates with higher albuminuria levels, even at lower thresholds than previously observed in diabetic populations.

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension Research

Background:

  • Albuminuria is a known risk factor for cardiovascular events.
  • Hypertensive patients with left ventricular hypertrophy (LVH) represent a high-risk population.
  • Previous studies suggested higher UACR thresholds for risk in non-diabetic populations.

Purpose of the Study:

  • To investigate the relationship between albuminuria (UACR) and cardiovascular risk.
  • To determine if a specific UACR threshold exists for increased cardiovascular risk in hypertensive patients with LVH.
  • To compare cardiovascular risk associated with UACR in this population to that reported in diabetic patients.

Main Methods:

  • Analysis of data from 8206 hypertensive patients with LVH in the LIFE Study.
  • Longitudinal follow-up of 39,122 patient-years.
  • Assessment of the primary composite cardiovascular end point in relation to baseline UACR deciles.

Main Results:

  • A continuous increase in cardiovascular risk was observed across UACR deciles, from lowest to highest.
  • No specific UACR threshold was identified below which risk was absent.
  • Albuminuria was confirmed as a significant predictor of cardiovascular outcomes in this cohort.

Conclusions:

  • Albuminuria is a potent predictor of cardiovascular morbidity and mortality in hypertensive patients with LVH.
  • The risk associated with albuminuria in this population emerges at lower UACR levels than previously reported for diabetic patients.
  • Continuous risk escalation underscores the importance of monitoring UACR in hypertensive individuals with LVH.

More Related Videos

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension07:38

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension

Published on: January 20, 2023

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...